Overview

A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children

Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
0
Participant gender:
All
Summary
This is a study to investigate the pharmacokinetics, safety and tolerability of several doses of voriconazole, intravenous and oral suspension formulations, in children
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pfizer
Treatments:
Voriconazole
Criteria
Inclusion Criteria:

- Children who require a systemic antifungal agent for the prevention of systemic fungal
infection

Exclusion Criteria:

- Children who are receiving medications which cannot be taken concomitantly with
voriconazole.